Home » Topics » Disease categories and therapies » Immune

Immune
RSS

LXR issued two U.S. patents for naturally occurring death receptor

Oct. 22, 1997

No Comments

Novartis granted option for TP-10 in xeno/allotransplants; preliminary results in lung transplant

Oct. 21, 1997

No Comments

Australian government awards Cortecs grant for otitis media research

Oct. 20, 1997

No Comments

Advisory panel to the FDA unanimously recommends PDL's Zenapax

Oct. 20, 1997

No Comments

VZV vaccines using gene product expressed during latency

Oct. 17, 1997

No Comments

BioTransplant and Novartis expand xenotransplantation collaboration

Oct. 15, 1997

No Comments

Magnetic protein conjugates from Behringwerke

Oct. 15, 1997

No Comments

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

No Comments

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

No Comments

Aviron updates vaccine clinical program

Oct. 10, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immune
RSS

LXR issued two U.S. patents for naturally occurring death receptor

Novartis granted option for TP-10 in xeno/allotransplants; preliminary results in lung transplant

Australian government awards Cortecs grant for otitis media research

Advisory panel to the FDA unanimously recommends PDL's Zenapax

VZV vaccines using gene product expressed during latency

BioTransplant and Novartis expand xenotransplantation collaboration

Magnetic protein conjugates from Behringwerke

LXR files IDE with FDA for heart preservation solution

Yoshitomi licenses immunosuppressant to Novartis

Aviron updates vaccine clinical program

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase III AMD miss leaves BLA Outlook same with bevacizumab

Immune RSS

Immune
RSS